Japanese encephalitis in the Western Pacific Region: Implication from the Republic of Korea.
Japanese encephalitis
Korea
Vaccine
Journal
Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899
Informations de publication
Date de publication:
17 03 2020
17 03 2020
Historique:
received:
13
12
2019
revised:
07
02
2020
accepted:
18
02
2020
pubmed:
1
3
2020
medline:
1
4
2021
entrez:
1
3
2020
Statut:
ppublish
Résumé
Japanese encephalitis (JE) is endemic in the Western Pacific Region. We aim to describe the regional status of control of JE, based on the World Health Organization (WHO) surveillance data, and to share the experience from the Republic of Korea. Substantial progress has been made in the region to date; however, epidemiologic changes have not been delineated. The vaccination coverage should be addressed to close the immunity gap. The lessons learned from Korea may aid in establishing a high-quality surveillance system with a sustainable JE vaccination program in order to prepare for new challenges that this region will face.
Identifiants
pubmed: 32111531
pii: S0264-410X(20)30284-X
doi: 10.1016/j.vaccine.2020.02.061
pii:
doi:
Substances chimiques
Japanese Encephalitis Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2760-2763Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Informations de copyright
Copyright © 2020. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.